| Title: |
Inhibition of Neural Crest Cell Migration by Strobilurin Fungicides and Other Mitochondrial Toxicants. |
| Authors: |
Magel, Viktoria1 (AUTHOR), Blum, Jonathan1 (AUTHOR), Dolde, Xenia1 (AUTHOR), Leisner, Heidrun1 (AUTHOR), Grillberger, Karin2 (AUTHOR), Khalidi, Hiba3 (AUTHOR), Gardner, Iain3 (AUTHOR), Ecker, Gerhard F.2 (AUTHOR), Pallocca, Giorgia1,4 (AUTHOR), Dreser, Nadine1,4 (AUTHOR), Leist, Marcel1,4 (AUTHOR) marcel.leist@uni-konstanz.de |
| Source: |
Cells (2073-4409). Dec2024, Vol. 13 Issue 24, p2057. 24p. |
| Subject Terms: |
*NEURAL crest, *NEURAL inhibition, *CELL migration, *DATA integration, *TOXICITY testing, *OXYGEN consumption |
| Abstract: |
Cell-based test methods with a phenotypic readout are frequently used for toxicity screening. However, guidance on how to validate the hits and how to integrate this information with other data for purposes of risk assessment is missing. We present here such a procedure and exemplify it with a case study on neural crest cell (NCC)-based developmental toxicity of picoxystrobin. A library of potential environmental toxicants was screened in the UKN2 assay, which simultaneously measures migration and cytotoxicity in NCC. Several strobilurin fungicides, known as inhibitors of the mitochondrial respiratory chain complex III, emerged as specific hits. From these, picoxystrobin was chosen to exemplify a roadmap leading from cell-based testing towards toxicological predictions. Following a stringent confirmatory testing, an adverse outcome pathway was developed to provide a testable toxicity hypothesis. Mechanistic studies showed that the oxygen consumption rate was inhibited at sub-µM picoxystrobin concentrations after a 24 h pre-exposure. Migration was inhibited in the 100 nM range, under assay conditions forcing cells to rely on mitochondria. Biokinetic modeling was used to predict intracellular concentrations. Assuming an oral intake of picoxystrobin, consistent with the acceptable daily intake level, physiologically based kinetic modeling suggested that brain concentrations of 0.1–1 µM may be reached. Using this broad array of hazard and toxicokinetics data, we calculated a margin of exposure ≥ 80 between the lowest in vitro point of departure and the highest predicted tissue concentration. Thus, our study exemplifies a hit follow-up strategy and contributes to paving the way to next-generation risk assessment. [ABSTRACT FROM AUTHOR] |
|
Copyright of Cells (2073-4409) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
